NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors treatment 2 active_not_recruiting NCT05142241
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial treatment 2 suspended NCT02402244
Project: Every Child for Younger Patients With Cancer No drug interventions Not Available Not Available recruiting NCT02186678
Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation No drug interventions diagnostic Not Available completed NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours treatment 1 / 2 recruiting NCT05636618
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors No drug interventions treatment 1 / 2 recruiting NCT06427798
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy treatment 1 / 2 not_yet_recruiting NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT06607692
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). treatment 2 recruiting NCT00107289
Iodine I 131 Metaiodobenzylguanidine in Treating Patients with Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma treatment 2 recruiting NCT06233903
18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System diagnostic 2 not_yet_recruiting NCT00004847
Diagnosis of Pheochromocytoma No drug interventions diagnostic 1 recruiting NCT03206060
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma treatment 2 recruiting NCT06573723
Institutional Registry of Rare Diseases No drug interventions Not Available Not Available recruiting NCT01413503
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors No drug interventions treatment 2 completed NCT05446779
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death No drug interventions Not Available Not Available active_not_recruiting NCT01838187
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma Not Available Not Available no_longer_available NCT06377033
Using the EHR to Advance Genomic Medicine Across a Diverse Health System No drug interventions health_services_research Not Available recruiting NCT00001147
Blood Sampling for Neurochemical and Genetic Testing No drug interventions Not Available Not Available completed NCT00002947
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer No drug interventions treatment 1 terminated NCT03839498
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma treatment 2 recruiting NCT05456997
Metabolic Myopathy in Endocrinopathy No drug interventions Not Available Not Available terminated NCT04071561
Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions No drug interventions Not Available Not Available completed NCT05082311
Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma No drug interventions Not Available Not Available completed NCT05053685
Metanephrines in Obstructive Sleep Apnoea No drug interventions Not Available Not Available completed NCT01022515
Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma No drug interventions Not Available Not Available completed NCT03474237
A Prospective Cohort Study for Patients With Adrenal Diseases No drug interventions Not Available Not Available enrolling_by_invitation NCT00028106
131MIBG to Treat Malignant Pheochromocytoma No drug interventions treatment 2 completed NCT04566406
Pheochromocytoma and Hemodynamic Instability No drug interventions Not Available Not Available completed NCT01373736
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors No drug interventions diagnostic 3 unknown_status NCT00188019
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers No drug interventions diagnostic Not Available completed NCT05451134
Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma No drug interventions Not Available Not Available unknown_status NCT04119024
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors treatment 1 recruiting NCT04573816
Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma No drug interventions Not Available Not Available unknown_status NCT00590096
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma No drug interventions Not Available Not Available completed NCT04711135
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs treatment 2 active_not_recruiting NCT04605848
Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) No drug interventions diagnostic Not Available terminated NCT00669266
Adrenal Tumors - Pathogenesis and Therapy No drug interventions Not Available Not Available recruiting NCT03160274
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions No drug interventions Not Available Not Available recruiting NCT04400474
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study treatment 2 active_not_recruiting NCT03541720
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma No drug interventions diagnostic 0 recruiting NCT06523582
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients No drug interventions Not Available Not Available recruiting NCT04788927
Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study No drug interventions Not Available Not Available not_yet_recruiting NCT03946527
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) treatment 2 recruiting NCT02618694
Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study No drug interventions treatment Not Available completed NCT00911729
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma No drug interventions Not Available Not Available terminated NCT00001229
Diagnosis and Treatment of Pheochromocytoma No drug interventions Not Available Not Available completed NCT04320589
the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma prevention 2 completed NCT04890444
China Adrenal Disease Registry No drug interventions Not Available Not Available recruiting NCT03015844
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma Not Available Not Available available NCT04187404
A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma treatment 1 / 2 active_not_recruiting NCT04557072
Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis Not Available Not Available completed NCT01425710
Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma No drug interventions Not Available Not Available completed NCT01949714
Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue No drug interventions Not Available Not Available completed NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors No drug interventions treatment 1 completed NCT00002764
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma treatment 3 completed NCT03165721
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer treatment 2 terminated NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT01379898
Phenoxybenzamine Versus Doxazosin in PCC Patients treatment 4 completed NCT06229405
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data No drug interventions Not Available Not Available recruiting NCT04276597
Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. treatment 2 withdrawn NCT06429397
First-line Anlotinib Combined With Penpulimab for Advanced Pheochromocytoma: A Single-arm, Multicenter, Prospective Phase II Study treatment 2 recruiting NCT03583528
DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT01959711
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy No drug interventions treatment 4 completed NCT03176693
Preoperative Alpha Blockade for Pheochromocytoma treatment 3 completed NCT03986593
Cryoablation of Bone Metastases From Endocrine Tumors No drug interventions treatment Not Available terminated NCT06444607
Hereditary Pheochromocytoma Assessment of Tumour Immunologies No drug interventions Not Available Not Available not_yet_recruiting NCT00466856
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors treatment 2 terminated NCT05883085
A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL treatment 2 recruiting NCT02431715
18F-FDOPA PET in Neuroendocrine Tumours No drug interventions Not Available Not Available no_longer_available NCT00843037
Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma treatment 2 completed NCT05948137
F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma No drug interventions Not Available Not Available terminated NCT01377532
Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma Not Available Not Available approved_for_marketing NCT00458952
Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma treatment 1 / 2 completed NCT00970970
Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease No drug interventions Not Available Not Available completed NCT03158870
Surgeon-Anesthesiologist Collaboration No drug interventions Not Available Not Available unknown_status NCT00002641
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma treatment 3 completed NCT03344016
Multicenter Pheochromocytoma and Paraganglioma Evaluation No drug interventions health_services_research Not Available recruiting NCT06037135
Dexmedetomidine Infusion During Laparoscopic Adrenalectomy supportive_care Not Available completed NCT05885386
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL treatment 2 recruiting NCT06440122
The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) No drug interventions Not Available Not Available recruiting NCT06050057
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy No drug interventions Not Available Not Available recruiting NCT03923257
Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents treatment 1 / 2 withdrawn NCT05069220
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor diagnostic 0 recruiting NCT06062082
Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma No drug interventions Not Available Not Available recruiting NCT00339131
ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid diagnostic 1 completed NCT01152827
RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid treatment 2 completed NCT01967576
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma treatment 2 completed NCT06045260
"Receptor Radionuclide Therapy With 177Lu-DOTATOC treatment 2 recruiting NCT02961491
Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma Not Available Not Available approved_for_marketing NCT01590680
Expanded Access Protocol Using 131I-MIBG No drug interventions Not Available Not Available available NCT05702944
The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma prevention 4 recruiting NCT05636540
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma No drug interventions diagnostic 0 recruiting NCT05158712
Genetic Factors and Pheochromocytomas in Neoplasia Type 2 No drug interventions Not Available Not Available recruiting NCT00126412
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma diagnostic 3 completed NCT04891081
Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease No drug interventions Not Available Not Available unknown_status NCT00923481
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... treatment 2 completed NCT00874614
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma No drug interventions treatment 2 unknown_status NCT00002608
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors treatment 2 completed NCT00436735
Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors treatment 1 active_not_recruiting NCT01941849
Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma treatment 1 withdrawn